Representatives in the White House continue to reach out to every outlet possible to try and encourage the spread of information surrounding state healthcare exchanges. Worries mount on whether or not Americans will be incentivized to buy in to the program.
Representatives in the White House continue to reach out to every outlet possible to try and encourage the spread of information surrounding state healthcare exchanges. Worries mount on whether or not Americans will be incentivized to buy in to the program. Forbes reports:
Actors. Actresses. NFL football players. Baseball players. Librarians. Mayors. City councilmen. Members of AARP.
The Obama administration is looking far and wide, leaving no stone unturned in a relentless search for…well…for help.
Help with what? Help with getting people to enroll in health insurance plans this fall.
And why is that? Because the administration is facing the very real possibility that its signature piece of legislation may fall flat on its face.
Last week’s announcement that the employer mandate will be delayed for a year and that income verification for people getting subsidies will also be delayed are the latest signs of trouble. The next shoe to drop may be the failure for people to obtain (ObamaCare) insurance — even if it’s free or highly subsidized.
Read the full story here: http://onforb.es/1bnInzS
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer
December 9th 2023This phase 3 study investigated sacituzumab govitecan, a Trop-2–directed antibody-drug conjugate, vs treatment of physician’s choice in pretreated patients who have endocrine-resistant hormone receptor–positive/HER2-negative breast cancer, the most common form of breast cancer.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More